cannabidiol/tetrahydrocannabinol (Accordion Pill Cannabidiol/Tetrahydrocannabinol)
/ Jazz, Indaptus Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 09, 2020
Intec Pharma jumps 65% after research pact with UK-based GW Pharma
(SeekingAlpha)
- "Intec Pharma (NASDAQ:NTEC) entered into a feasibility agreement with London-based GW Research to explore using the Accordion Pill (AP) platform for an undisclosed research program....Shares are up 64.5% PM."
Licensing / partnership • Stock price • CNS Disorders
October 08, 2020
Intec Pharma Announces New Research Collaboration Agreement with MSD
(PRNewswire)
- "Intec Pharma...today announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential."
Licensing / partnership • CNS Disorders
March 13, 2020
Intec Pharma reports fourth quarter and year end 2019 financial results and corporate update
(BioSpace)
- "Developed an Accordion Pill (AP) for a Merck & Co. (MSD) proprietary compound that met the in vitro specifications set forth in the companies' research collaboration and are now in discussions with MSD to determine advancing the program into human pharmacokinetic (PK) studies..."
PK/PD data
1 to 3
Of
3
Go to page
1